RE:Biotech analysis criteria run throughThey failed covid trials with 1 patient tested = raza bokhari leadership he was ceo
cannabis venture failed = Thomas fairfull leadership he was the ceo of FV Pharma
lucid acquisition was done by none of the previous leadership roles now it's on current management to grow value
current management and leadership with real updates
phase 2 trials currently recruitment for FSD PEA and mast cells idiopathic pain green light with 60 patients total with a mast cell diagnosis
Health Canada green light for lucid MS trials this tests healthy subjects
Phase 1 and Phase 2 trials are two stages of the clinical trial process for testing the safety and efficacy of new drugs or therapies. Here are the main differences between the two phases:
Purpose: Phase 1 trials are primarily focused on assessing the safety of the new drug or therapy, determining the appropriate dose range, and identifying any potential side effects. Phase 2 trials are designed to evaluate the drug or therapy's effectiveness in treating the targeted condition and to further assess safety.
Participants: Phase 1 trials typically involve a small number of healthy volunteers (typically fewer than 100 participants) who are closely monitored for safety and potential side effects. Phase 2 trials involve a larger number of participants (usually between 100 and 300) who have the condition the drug or therapy is intended to treat.
Duration: Phase 1 trials are generally shorter in duration, typically lasting a few months, while Phase 2 trials may take several months to a few years.
Endpoints: In Phase 1 trials, the main endpoint is typically safety and tolerability, while in Phase 2 trials, the primary endpoint is often the drug or therapy's effectiveness in treating the targeted condition.
Design: Phase 1 trials are usually designed as single-arm studies, with all participants receiving the new drug or therapy. In contrast, Phase 2 trials may be designed as randomized, controlled trials, where some participants receive the new drug or therapy and others receive a placebo or standard treatment.
Overall, while both Phase 1 and Phase 2 trials are important stages in the clinical trial process, they serve different purposes and involve different types of participants and study designs.